Attitudes to Abortion, Methadone Maintenance and Humane Opiate Withdrawal Among Health Professionals: A Depressing Analogy

References

• Abed R. T., Neira-Munoz E. A survey of general pratitioners' opinion and attitude to drug addicts and addiction. British Journal of Addiction 1990; 85: 131–136
   PubMedGoogle Scholar
• Berridge V., Edwards G. Opium and the people. Yale University Press., New Haven 1987
   Google Scholar
• Brewer C. Third time unlucky: a study of women who have three or more legal abortions. Journal of Biosocial Science 1977; 9: 99–105
   PubMed Web of Science ®Google Scholar
• Brewer C. Induced abortion after feeling foetal movements: its causes and emotional consequences. Journal of Biosocial Science 1978; 10: 203–208
   PubMed Web of Science ®Google Scholar
• Brewer C, Rezae H., Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours using a modification of the naltrexone-clonidine technique. British Journal of Psychiatry 1988; 153: 340–343
   PubMed Web of Science ®Google Scholar
• Brewer C. Naltrexone in the prevention of relapse and opiate detoxification. Treatment Options in Addiction–Medical management of alcohol and opiate abuse, C Brewer. Gaskell/Royal College of Psychiatrists, London 1993
   Google Scholar
• Brewer C. On the specific effectiveness, and undervaluing, of pharmacological treatments for addiction: a comparison of methadone, naltrexone and disulfiram with psychosocial interventions. Addiction Research, In press
   Google Scholar
• Caplehorn J., Dalton S., Cluff M., Petrenas A-M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89: 203–207
   PubMed Web of Science ®Google Scholar
• Caplehorn J. Methadone maintenance treatment: Britain has been overcommitted to psychological theories of drug dependence. British Medical Journal 1995; 310: 463
   PubMedGoogle Scholar
• Charney D. S., Henninger G. R., Kleber H. The combined use of clonidine and naltrexone as a safe, rapid and effective treatment of abrupt withdrawal from methadone. American Journal of Psychiatry 1986; 143: 831–837
   PubMed Web of Science ®Google Scholar
• Deglon J-J. (1993) Reducing heroin consumption during methadone treatment and limitation of post-treatment relapses: two crucial public health problems. Paper presented at the Second European Symposium on Drug Addiction and AIDS. Oct, 4-61993. Siena
   Google Scholar
• De Quincey T. Confessions of an english opium-eater. Oxford University Press, Oxford 1985
   Google Scholar
• Farrell M. Opiate withdrawal. Addiction 1994; 89: 1471–1475
   PubMed Web of Science ®Google Scholar
• Farrell M., Ward J., Mattick R., Hall W., Stimson G., Des Jarlais D., Gossop M., Strang J. Methadone maintenance treatment in opiate dependence: a review. British Medical Journal 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Gerra G., Marcato A., Caccavari R. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. Journal of Substance Abuse Treatment 1995; 12: 35–41
   PubMed Web of Science ®Google Scholar
• Gossop M., Johns A., Green L. Opiate withdrawal: in-patient versus out-patient programmesa and preferred versus random assignment to treatment. British Medical Journal 1987; 293: 103–104
   Google Scholar
• Gottheil E., Sterling R., Weinstein S. Diminished illicit drug use as a consequence of long-term methadone maintenance. Journal of Addictive Diseases 1993; 12: 45–57
   PubMedGoogle Scholar
• Greenwood J. Persuading general practitioners to prescribe–good husbandry or a recipe for chaos?. British Journal of Addiction 1992; 87(4)567–575
   PubMedGoogle Scholar
• Kleber H. D., Kosten T. R. Naltrexone induction: psychologic and pharmacologic strategies. Journal of Clinical Psychiatry 1984; 45: 29–38
   PubMed Web of Science ®Google Scholar
• Kosten T, Jacobsen L., Kosten T. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. American Journal of Drug and Alcohol Abuse 1989; 15: 237–250
   PubMed Web of Science ®Google Scholar
• Liappas I. Thoughts on the Sheffield non-prescription programme for narcotic users. British Journal of Addiction 1987; 82: 999–1006
   PubMedGoogle Scholar
• Loimer N., Schmid R., Presslich O., Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. Journal of Psychiatric Research 1988; 23: 81–86
   Web of Science ®Google Scholar
• Loimer N., Schmid R., Presslich O., Lenz K. Naloxone treatment for opiate withdrawal syndrome. British Journal of Psychiatry 1988b; 155: 851–852
   Google Scholar
• Loimer N., Presslich O., Lenz K., Pfersmann D., Schmid R., Fodor G., Aschauer G. Die “induzierte entzugsbehandlung” bei opiatabhangigen–ein neues therapiekonzept. Wiener Klinische Wochenschrift 1989; 101: 451–454
   PubMedGoogle Scholar
• Loimer N., Schmid R., Lenz K., Presslich O., Grunberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. British Journal of Psychiatry 1990; 157: 748–752
   PubMed Web of Science ®Google Scholar
• Loimer N., Lenz K., Schmid R., Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. American Journal of Psychiatry 1991; 148: 933–935
   PubMed Web of Science ®Google Scholar
• Madden J. S. The International Handbook of Addiction Behaviour, I. B. Glass. Tavistock, London 1991
   Google Scholar
• Marks J. The paradox of prohibition. Treatment Options in Addiction: medical management of alcohol and opiate abuse, C. Brewer. Gaskell/Royal College of Psychiatrists, London 1993
   Google Scholar
• Mathew R. J., Georgi J., Nagy P. Substance abuse treatment: beyond the Minnesota Model. North Carolina Medical Journal 1994; 55: 224–226
   PubMedGoogle Scholar
• Newman R., Whitehill W. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 1979; 2: 485–488
   PubMed Web of Science ®Google Scholar
• Presslich O., Loimer N., Lenz K., Schmid R. Opiate detoxification under general anaesthesia by large doses of naloxone. Clinical Toxicology 1989; 27: 263–270
   Web of Science ®Google Scholar
• Senft R. A. Experience with clonidine-naltrexone for rapid opiate detoxification. Journal of Substance Abuse Treatment 1991; 8: 257–259
   PubMed Web of Science ®Google Scholar
• Shufman E. N., Porat S., Witztum E., Bar-Hamburger R., Gandacu D. The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry 1994; 35: 935–945
   PubMed Web of Science ®Google Scholar
• Suzuki T., Koike Y., Yanaura S. Genetic differences in the development of physical dependence on pentobarbital in four inbred strains of rats. Japanese Journal of Pharmacology 1987; 45: 479–486
   PubMedGoogle Scholar
• Tilly J., Cornish J., Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P. Naltrexone and the treatment of federal probationers. NIDA Research Monograph 1991; 119: 458
   Google Scholar
• Vanichseni S., Wongsuwan B. A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV. International Journal of Addictions 1991; 26: 1313–1320
   PubMed Web of Science ®Google Scholar
• Vining E., Kosten T., Kleber H. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. British Journal of Addiction 1988; 83: 567–575
   PubMedGoogle Scholar
• Weinstein S. P., Gottheil E., Sterling R. C., De Maria P. A. Long-Term Methadone Maintenance Treatment: Some Clinical Examples. Journal of Substance Abuse Treatment 1993; 10: 277–281
   PubMed Web of Science ®Google Scholar